The recently passed federal defense budget for 2026 includes dedicated funding for the use of bioengineered blood vessels ...

The rising incidence of cancer worldwide has led to an increasing number of surgeries that involve the removal of lymph nodes. Although these procedures play a major role in cancer staging and ...

Explore the innovative concept of bioengineered lymph nodes as a promising solution for lymphedema after cancer surgery.

On Thursday, the FDA granted full approval to Humacyte, Inc.’s (NASDAQ:HUMA) Symvess (acellular tissue-engineered vessel-tyod) use in adults as a vascular conduit for extremity arterial injury when ...

The demand for eco-friendly alternatives to traditional packaging materials has never been higher. As global environmental concerns escalate, industries are increasingly exploring innovative ways to ...

Researchers developed bioengineered lymphatic tissue that replaced missing lymph nodes in mice, with potential to treat lymphedema.

Bacterial cellulose (BC) has emerged as a promising biopolymer across diverse sectors, ranging from biomedicine, food packaging, electronics, and textiles, ...